Next generation TAVI with the Lotus Valve System: a repositionable and fully retrievable transcatheter aortic valve prosthesis

Murdoch, D., Shaw, E., Raffel, O. C. and Walters, D. L. (2015) Next generation TAVI with the Lotus Valve System: a repositionable and fully retrievable transcatheter aortic valve prosthesis. Minerva Cardioangiologica, 63 4: 343-357.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
Author Murdoch, D.
Shaw, E.
Raffel, O. C.
Walters, D. L.
Title Next generation TAVI with the Lotus Valve System: a repositionable and fully retrievable transcatheter aortic valve prosthesis
Journal name Minerva Cardioangiologica   Check publisher's open access policy
ISSN 0026-4725
1827-1618
Publication date 2015-08-01
Sub-type Critical review of research, literature review, critical commentary
Open Access Status Not Open Access
Volume 63
Issue 4
Start page 343
End page 357
Total pages 15
Place of publication Turin, Italy
Publisher Edizioni Minerva Medica
Language eng
Abstract Transcatheter aortic valve implantation (TAVI) is the new standard of care for selected patients with severe symptomatic aortic stenosis who are at high risk for surgical aortic valve replacement (AVR), or are inoperable. Multicentre randomised controlled trials have demonstrated equivalent or superior clinical outcomes for TAVI compared to AVR in carefully selected patient cohorts. A number of important limitations were observed with early generation TAVI valves and their delivery systems, and rapid evolution of the technology continues. The Lotus Valve System aims to address a number of these limitations – it is repositionable and retrievable, and has an adaptive seal to prevent paravalvular aortic regurgitation. Early clinical outcomes for the Lotus Valve System have recently been published with promising results in terms of paravalvular regurgitation and repositionability.
Keyword Aortic valve stenosis
Transcatheter aortic valve replacement
Heart valve diseases
Bioprosthetic Surgical Valves
Valvular Heart-Disease
High-Risk Patients
Implantation Tavi
Clinical-Outcomes
Replacement
Registry
Guidelines
Management
Evolution
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Official 2016 Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 08 Nov 2015, 10:17:03 EST by System User on behalf of Scholarly Communication and Digitisation Service